EP3218061 - Bibliographic data
COMPOSITION PHARMACEUTIQUE DE CARMUSTINE
| Last update | 06/06/2025 |
|---|---|
| Legal status | Brevet déchu |
| Origin | Euro-PCT |
| (73) Holder |
Navinta III Inc 1003 Clint Moore Road
Boca Raton, FL 33487
États-Unis d'Amérique
|
|---|---|
| (72) Inventors |
Mahendra R. PATEL 5 Bel Air Court
Milltown, NJ 08850
États-Unis d'Amérique
|
| (74) Agent |
Mail recipient Patentgruppen A/S Aaboulevarden 31, 4th Floor
8000 Aarhus C
Danemark
|
| (21) Request number | EP15859861.5 |
|---|---|
| (22) Request date | 11/11/2015 |
| (11) Publication number | EP3218061 |
|---|---|
| Publication date | 29/06/2022 |
| (54) Title of the invention | COMPOSITION PHARMACEUTIQUE DE CARMUSTINE |
|---|---|
| (51) International classification | A61K 9/19, A61K 47/10, A61P 35/00, A61K 31/17, A61K 31/175 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 201462080091 P |
|---|---|
| Initial application | None |
| Divisional application | None |
| Expected annuity |
Annuity: 8 -
Amount: 150 € -
Due date 30/11/2022
Surtax: 8 - Amount: 30 € - Due date 01/06/2023 |
|---|---|
| Last annuity | None |
| Publication | None |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 29/06/2022 Entrée en période de grâce du brevet d'invention - Legal date 01/12/2022 Déchéance du brevet d'invention après période de grâce - Legal date 30/11/2022 |